Global Non-mydriatic Retinal Camera Market Size By Type (Hand-held, Desktop), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Non-Mydriatic Retinal Camera Market was valued at USD 425 million in 2023 and is projected to reach USD 678 million by 2031, growing at a CAGR of 6.1% during the forecast period from 2023 to 2031. The market is being driven by the increasing prevalence of diabetic retinopathy and age-related macular degeneration (AMD), rising demand for early and non-invasive diagnosis of retinal diseases, and the adoption of portable and user-friendly imaging devices across ophthalmology clinics and primary care settings. The integration of AI-driven image analysis and electronic medical record (EMR) compatibility is further boosting adoption, especially in remote and resource-limited environments.

Drivers:

1. Growing Burden of Retinal Diseases:

The increasing global incidence of diabetes and age-related visual impairments is fueling the demand for accessible retinal imaging solutions. Non-mydriatic retinal cameras allow for fast, pupil dilation-free diagnostics, making them ideal for large-scale screening programs.

2. Advancements in Imaging Technology:

Innovations such as hybrid cameras with optical coherence tomography (OCT) functionality, high-resolution sensors, and AI-based diagnostic tools are improving imaging accuracy and workflow efficiency.

3. Expansion of Primary Eye Care Services:

The shift towards decentralized healthcare delivery has increased the deployment of compact and cost-effective non-mydriatic cameras in primary care centers, optical retail chains, and mobile screening units.

Restraints:

1. High Initial Setup Cost:

While non-mydriatic cameras are more affordable than traditional systems, their cost remains a barrier for small practices and facilities in low-income regions.

2. Limited Skilled Personnel for Interpretation:

Proper interpretation of retinal images still often requires trained ophthalmologists or integration with AI analysis, which may not be readily available in all locations.

Opportunity:

1. Integration with Teleophthalmology and AI Diagnostics:

Growing telemedicine initiatives and AI-enhanced image interpretation open up new avenues for remote screening and early detection of eye diseases in underserved areas.

2. Emerging Markets and Portable Devices:

Compact, battery-operated devices designed for use in rural and low-resource settings are expanding market penetration, especially in Asia-Pacific, Latin America, and Sub-Saharan Africa.

Market by System Type Insights:

The Tabletop Non-Mydriatic Retinal Cameras segment held the largest market share in 2023 due to its widespread use in specialty ophthalmology clinics and hospitals. However, the Handheld Non-Mydriatic Retinal Cameras segment is anticipated to register the fastest growth during the forecast period. Portability, ease of use, and increasing deployment in mobile screening programs are driving the demand for handheld units.

Market by End-use Insights:

The Hospitals & Ophthalmic Clinics segment accounted for the largest revenue share in 2023, owing to the high patient volume and integration of retinal cameras into specialized diagnostic pathways. Meanwhile, the Primary Healthcare Centers and Retail Eye Care Chains segments are expected to witness robust growth due to the expansion of decentralized vision screening services.

Market by Regional Insights:

North America led the market in 2023, benefiting from a well-established healthcare infrastructure, advanced reimbursement policies, and a high prevalence of diabetic retinopathy. Asia-Pacific is projected to exhibit the highest CAGR during the forecast period, driven by increasing healthcare investments, growing awareness of eye health, and expanding diabetic populations in countries such as India and China.

Competitive Scenario:

Key players in the Global Non-Mydriatic Retinal Camera Market include Canon Inc., Topcon Corporation, NIDEK Co., Ltd., Optomed Plc, Kowa Company Ltd., Carl Zeiss Meditec AG, CenterVue SpA, Eyenuk Inc., Remidio Innovative Solutions Pvt. Ltd., and Volk Optical Inc. These companies are investing in product innovations, AI integration, and strategic collaborations to expand their market presence.

Scope of Work – Global Non-Mydriatic Retinal Camera Market

Report Metric Details

Market Size (2023) USD 425 million

Projected Market Size (2031) USD 678 million

CAGR (2023–2031) 6.1%

Market Segments By System Type, By End-use, By Region

Growth Drivers Increasing diabetic retinopathy cases, adoption of AI imaging

Opportunities Teleophthalmology integration, portable screening devices

Key Market Developments:

April 2024: Topcon Corporation introduced an AI-integrated non-mydriatic camera with instant screening capabilities for diabetic retinopathy, designed for primary care integration.

January 2024: Optomed launched a cloud-connected handheld retinal camera for rural outreach programs in Southeast Asia.

September 2023: Canon Inc. partnered with a leading EMR software provider to enable seamless data integration for its CX-1 hybrid camera systems.

FAQs:

1) What is the current market size of the Global Non-Mydriatic Retinal Camera Market?

The market was valued at USD 425 million in 2023.

2) What is the major growth driver of the Global Non-Mydriatic Retinal Camera Market?

The major growth driver is the rising prevalence of diabetic retinopathy and the demand for non-invasive retinal screening.

3) Which is the largest region during the forecast period in the Global Non-Mydriatic Retinal Camera Market?

No